Toulouse, France

Caroline Imbert

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Caroline Imbert: Innovator in Immune Checkpoint Inhibitors

Introduction

Caroline Imbert is a notable inventor based in Toulouse, France. She has made significant contributions to the field of immunology, particularly in enhancing the effectiveness of immune checkpoint inhibitors. Her innovative approaches have the potential to improve treatment regimens for patients undergoing immunotherapy.

Latest Patents

Caroline Imbert holds a patent titled "Methods for enhancing the potency of the immune checkpoint inhibitors." This invention relates to methods that enhance the potency of immune checkpoint inhibitors administered to subjects as part of a treatment regimen. Specifically, the method involves administering a pharmaceutically effective amount of a SK1 inhibitor in combination with the immune checkpoint inhibitor to improve treatment outcomes.

Career Highlights

Throughout her career, Caroline has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université Toulouse III – Paul Sabatier. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Caroline has collaborated with notable colleagues, including Thierry Levade and Nicolas Meyer. These partnerships have fostered a rich environment for innovation and have led to advancements in the understanding of immune therapies.

Conclusion

Caroline Imbert's work in enhancing immune checkpoint inhibitors showcases her dedication to improving patient care through innovative research. Her contributions to the field of immunology are invaluable and continue to inspire future advancements in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…